Metraipolis › archive › dc_8244ea6ee41f

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir… — Europe PMC PMID:42278882

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42278882
DOI
10.3390/jcm15114021
License (as archived)
solo-consultazione
Archived
2026-11-01T09:40:39.453Z
SHA-256 of the archived text
644fef8893b02d649252de28882370729abc75efa53cd45c0ceadc40c59d816a
Stable URL of this page
https://metraipolis.com/documento/dc_8244ea6ee41f

How to cite

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir… — Europe PMC PMID:42278882 — Europe PMC (en), https://europepmc.org/article/MED/42278882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8244ea6ee41f (Metraipolis archive dc_8244ea6ee41f, sha256 644fef8893b02d649252de28882370729abc75efa53cd45c0ceadc40c59d816a)
BibTeX
@misc{dc8244ea6ee41f,
  title = {Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir… — Europe PMC PMID:42278882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42278882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8244ea6ee41f; sha256 644fef8893b02d649252de28882370729abc75efa53cd45c0ceadc40c59d816a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278882. Agents can read the archived copy with the MCP tool read_document.